The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...